|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2000-4-3
|
|
pubmed:abstractText |
To compare the antiviral activity, safety and tolerability of didanosine dosed once and twice daily when administered in combination with stavudine dosed twice daily in human immunodeficiency virus type 1 (HIV-1)-infected individuals with little or no previous exposure to antiretroviral drugs.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
195-202
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10723498-Adult,
pubmed-meshheading:10723498-Aged,
pubmed-meshheading:10723498-Anti-HIV Agents,
pubmed-meshheading:10723498-CD4 Lymphocyte Count,
pubmed-meshheading:10723498-Didanosine,
pubmed-meshheading:10723498-Drug Therapy, Combination,
pubmed-meshheading:10723498-Female,
pubmed-meshheading:10723498-HIV Infections,
pubmed-meshheading:10723498-HIV-1,
pubmed-meshheading:10723498-Humans,
pubmed-meshheading:10723498-Male,
pubmed-meshheading:10723498-Middle Aged,
pubmed-meshheading:10723498-RNA, Viral,
pubmed-meshheading:10723498-Reverse Transcriptase Inhibitors,
pubmed-meshheading:10723498-Risk Factors,
pubmed-meshheading:10723498-Stavudine
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Comparison of once and twice daily dosing of didanosine in combination with stavudine for the treatment of HIV-1 infection. AI 454-146 Team.
|
|
pubmed:affiliation |
University of Bari, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
